Procter & Gamble Articles

NEW YORK STOCK COMMENT

6 December 1993

PREPARING FOR THE NEW US OTC MARKET

29 November 1993

SMITHKLINE BEECHAM GIVING TAGAMET REBATES

15 November 1993

POSITIVE OUTLOOK FOR OTCs IN LATIN AMERICAN

15 November 1993

MARKET WARMS TO COUGH & COLD SEASON IN USA

1 November 1993

MYLAN'S NAPROXEN APPROVED IN USA

13 September 1993

UK TO DELIST 62 MORE MEDICINES FROM NHS

23 August 1993

SELF MEDICATION TO PASS $27BILLION IN MAJOR MARKETS

23 August 1993

IMPLICATIONS OF NAPROXEN STALL

14 June 1993

NAPROXEN DENIED OTC STATUS IN USA?

7 June 1993

UK OTC MARKET GROWTH FORECASTS TO 1997

31 May 1993

OTC GASTROINTESTINALS IN THE USA

24 May 1993

NEW PRESIDENT AT PROCTER & GAMBLE

19 April 1993

PROCTER & GAMBLE TERMINATE PFIZER AGREEMENT

19 April 1993

US 4th QTR SHOWS NOT ALL COMPANIES STRONG

15 February 1993

FDA APPROVES 26 NEWDRUGS IN 1992

25 January 1993

US OTC ANALGESICS - A 1992 RETROSPECTIVE

4 January 1993

ROBERTS ACQUIRES PRODUCT FROM PROCTER & GAMBLE

21 December 1992

PFIZER RESOLVE ROW WITH FRENCH GOVT

9 November 1992

ISRAEL CHEMICALS IN GERMAN ACQUISITION

5 October 1992

PROCTER & GAMBLE TISSUE CULTURE

5 October 1992

PROCTER & GAMBLE JOINT VENTURE

5 October 1992

PROCTOR AND GAMBLE PROMOTIONS

3 August 1992

THE CHANGING MARKET FOR HERBAL MEDICINES

29 June 1992

Rx-to-OTC switch - key to OTC market in USA By Mick Maroney, manager, North

1 June 1992

PROCTER & GAMBLE'S WOLFGANG BERNDT

25 May 1992

SUPPORTIVE CARE DRUGS IN CANCER: ASCO DATA

25 May 1992

P&G STAKE IN ROEHM PHARMA

18 May 1992

EUROPEAN MARKET FOR SELF-MEDICATION

18 May 1992

FISONS DIVESTS TO FOCUS ON PHARMACEUTICALS

11 May 1992

US APPROVAL FOR P&G'S MACROBID

20 January 1992

FDA DELAYS: COMPANIES URGE PATENT EXTENSION

13 January 1992

ANALGESICS IN THE USA -- AN OPEN DOOR FOR P&G?

6 January 1992

WORLD OTC MARKETS STUDIED

6 January 1992

Showing 301-334 of 334 articles

Go to beginningPreviousNextGo to end